Close

Novavax's (NVAX) RSV F Vaccine Granted FDA Fast-Track Designation

May 25, 2016 9:14 AM EDT Send to a Friend
Novavax, Inc. (Nasdaq: NVAX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Novavax’ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login